To estimate the levels of serum zinc, copper and prostate specific antigen in patients with benign prostatic hyperplasia (BPH) and prostate carcinoma (PCa) and to correlate their levels as screening test in the diagnosis of prostate neoplasms. Serum zinc and copper were estimated in 25 patients of BPH and 18 patients with PCa over a period of one year. All patients were males and aged between 5...

Radio Frequency Identification (RFID) provides an opportunity to explore a new approach with regards to information management and demonstrates an evolved business paradigm shift with regards to the Logistics Flows within Supply Chain Management of Blood Pack Handling (BPH). BPH is a mission-critical activity within the medical community and life sciences industry, Applications of RFID should n...

Benign prostatic hyperplasia (BPH) is a common disease in elderly men. Although it is a nonmalignant disease, it can have a significant impact on the quality of life of elderly men. The pumpkin seed is claimed to be useful in the management of BPH. This investigation analysed the chemical composition of pumpkin seeds and examined its effect on citral-induced hyperplasia of the prostate in Wista...

Red blood distribution width (RDW) is a novel prognostic marker that reflects oxidative stress and inflammation in patients. Chronic inflammation has been proposed as a candidate mechanism between benign prostatic hyperplasia (BPH) and metabolic syndrome (MetS). However, the relationship between RDW and MetS in BPH patients is unclear. Men aged 50 year-old or older with BPH were recruited into ...

BACKGROUND Recent studies showed that the non-adherence to the pharmacological therapy of patients affected by BPH-associated LUTS increased the risk of clinical progression of BPH. We examined the patients adherence to pharmacological therapy and its clinical consequences in men with BPH-associated LUTS looking at the differences between drug classes comparing mono vs combination therapy. ME...

Benign prostatic hyperplasia (BPH) is an age-related disease of unknown aetiology characterized by prostatic enlargement coincident with distinct alterations in tissue histomorphology. Instead of therapeutic agents that can cause severe side effects, plant extracts are frequently used to treat BPH. In this study, we investigated whether the Melandrium firmum methanolic extract (MFME) improves B...

Benign prostatic hyperplasia (BPH) is linked to lower urinary tract symptoms (LUTS) such as incomplete bladder emptying, urinary frequency and urgency. Mechanisms responsible for BPH are not fully known. Here, we tested whether beta-catenin (CTNNB1) immunostaining intensity and distribution differ in human glandular BPH tissue specimens compared to normal prostate tissue. Multiplex immunostaini...

Context: Pharmacological therapy for relieving lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) has evolved during the past years. The possible benefits of combination therapies to prevent disease progression or to treat LUTS/BPH with concomitant overactive bladder (OAB) or erectile dysfunction (ED) are currently studied. Objectives: To review the evidence prov...

BACKGROUND Despite the high prevalence of clinical benign prostatic hyperplasia (BPH) among older men, there remains a notable absence of studies focused on BPH prevention. OBJECTIVE To determine if finasteride prevents incident clinical BPH in healthy older men. DESIGN, SETTING, AND PARTICIPANTS Data for this study are from the Prostate Cancer Prevention Trial. After excluding those with a...